EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4(+) cytotoxic T cell recognition of EBV-transformed B cell lines

Tracey Haigh, XR Lin, Hui Jia, EP Hui, ATC Chan, Alan Rickinson, Graham Taylor

Research output: Contribution to journal › Article

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4(+) cytotoxic T cell recognition of EBV-transformed B cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences